Topology and Membrane Anchoring of the Lysosomal Storage Disease-Related Protein CLN5

Human Mutation

Volumn 34, Issue 12, 2013, Pages 1688-1697

  Larkin, Heidi ^a   Ribeiro, Maria Gil ^b,c   Lavoie, Christine ^a  

^a UNIVERSITY OF SHERBROOKE   (Canada)

^b NATIONAL INSTITUTE OF HEALTH   (Portugal)

^c UNIVERSIDADE FERNANDO PESSOA   (Portugal)

Author keywords

Amphipathic helix; CLN5; Neuronal ceroid lipofuscinoses (NCL); Topology; Transmembrane domain

Indexed keywords

EPITOPE; GLYCOPROTEIN; PROTEASOME; PROTEIN CLN5; SIGNAL PEPTIDE; UNCLASSIFIED DRUG;

ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; ENDOPLASMIC RETICULUM; HUMAN; HUMAN CELL; NEURONAL CEROID LIPOFUSCINOSIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN CONFORMATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PROTEIN SECRETION; PROTEIN SYNTHESIS; PROTEIN TRANSPORT; SOLUBILITY;

AMPHIPATHIC HELIX; CLN5; NEURONAL CEROID LIPOFUSCINOSES (NCL); TOPOLOGY; TRANSMEMBRANE DOMAIN;

AMINO ACID SEQUENCE; CELL LINE; GENE EXPRESSION; HUMANS; MEMBRANE PROTEINS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTATION; NEURONAL CEROID-LIPOFUSCINOSES; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN TRANSPORT; RECOMBINANT FUSION PROTEINS; SEQUENCE ALIGNMENT;

EID: 84887616942     PISSN: 10597794     EISSN: 10981004     Source Type: Journal    
DOI: 10.1002/humu.22443     Document Type: Article

References (33)

1. Bessa C, Teixeira CA, Mangas M, Dias A, Sa Miranda MC, Guimaraes A, Ferreira JC, Canas N, Cabral P, Ribeiro MG. 2006. Two novel CLN5 mutations in a Portuguese patient with vLINCL: insights into molecular mechanisms of CLN5 deficiency. Mol Genet Metab 89:245-253.
2. Bordier C. 1981. Phase separation of integral membrane proteins in Triton X-114 solution. J Biol Chem 256:1604-1607.
3. Boucrot E, Pick A, Camdere G, Liska N, Evergren E, McMahon HT, Kozlov MM. 2012. Membrane fission is promoted by insertion of amphipathic helices and is restricted by crescent BAR domains. Cell 149:124-136.
4. Burrack S, Aberle D, Burck J, Ulrich AS, Meyers G. 2012. A new type of intracellular retention signal identified in a pestivirus structural glycoprotein. FASEB J 26:3292-3305.
5. Cornell RB, Taneva SG. 2006. Amphipathic helices as mediators of the membrane interaction of amphitropic proteins, and as modulators of bilayer physical properties. Curr Protein Pept Sci 7:539-552.
6. Fetzer C, Tews BA, Meyers G. 2005. The carboxy-terminal sequence of the pestivirus glycoprotein E(rns) represents an unusual type of membrane anchor. J Virol 79:11901-11913.
7. Haltia M. 2006. The neuronal ceroid-lipofuscinoses: from past to present. Biochim Biophys Acta 1762:850-856.
8. Holmberg V, Jalanko A, Isosomppi J, Fabritius AL, Peltonen L, Kopra O. 2004. The mouse ortholog of the neuronal ceroid lipofuscinosis CLN5 gene encodes a soluble lysosomal glycoprotein expressed in the developing brain. Neurobiol Dis 16:29-40.
9. Holmberg V, Lauronen L, Autti T, Santavuori P, Savukoski M, Uvebrant P, Hofman I, Peltonen L, Jarvela I. 2000. Phenotype-genotype correlation in eight patients with Finnish variant late infantile NCL (CLN5). Neurology 55:579-581.
10. Isosomppi J, Vesa J, Jalanko A, Peltonen L. 2002. Lysosomal localization of the neuronal ceroid lipofuscinosis CLN5 protein. Hum Mol Genet 11:885-891.
11. Kollmann K, Mutenda KE, Balleininger M, Eckermann E, von Figura K, Schmidt B, Lubke T. 2005. Identification of novel lysosomal matrix proteins by proteome analysis. Proteomics 5:3966-3978.
12. Kollmann K, Uusi-Rauva K, Scifo E, Tyynela J, Jalanko A, Braulke T. 2013. Cell biology and function of neuronal ceroid lipofuscinosis-related proteins. Biochim Biophys Acta 1832:1866-1881.
13. Lebrun AH, Storch S, Ruschendorf F, Schmiedt ML, Kyttala A, Mole SE, Kitzmuller C, Saar K, Mewasingh LD, Boda V, Kohlschütter A, Ullrich K, Braulke T, Schulz A. 2009. Retention of lysosomal protein CLN5 in the endoplasmic reticulum causes neuronal ceroid lipofuscinosis in Asian sibship. Hum Mutat 30:E651-E661.
14. Lyly A, von Schantz C, Heine C, Schmiedt ML, Sipila T, Jalanko A, Kyttala A. 2009. Novel interactions of CLN5 support molecular networking between Neuronal Ceroid Lipofuscinosis proteins. BMC Cell Biol 10:83.
15. Mamo A, Jules F, Dumaresq-Doiron K, Costantino S, Lefrancois S. 2012. The role of ceroid lipofuscinosis neuronal protein 5 (CLN5) in endosomal sorting. Mol Cell Biol 32:1855-1866.
16. Matlin KS, Simons K. 1983. Reduced temperature prevents transfer of a membrane glycoprotein to the cell surface but does not prevent terminal glycosylation. Cell 34:233-243.
17. Mole SE, Williams RE, Goebel HH. 2005. Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses. Neurogenetics 6:107-126.
18. Mole SE, Williams RE, Goebel HH. 2011. The neuronal ceroid lipofuscinoses (Batten disease). In: Mole SE, Williams RE, Goebel HH, editors. New York: Oxford University Press. p 444.
19. Moore SJ, Buckley DJ, MacMillan A, Marshall HD, Steele L, Ray PN, Nawaz Z, Baskin B, Frecker M, Carr SM, Ives E, Parfrey PS. 2008. The clinical and genetic epidemiology of neuronal ceroid lipofuscinosis in Newfoundland. Clin Genet 74:213-222.
20. Nugent T, Mole SE, Jones DT. 2008. The transmembrane topology of Batten disease protein CLN3 determined by consensus computational prediction constrained by experimental data. FEBS Lett 582:1019-1024.
21. Qoronfleh MW, Benton B, Ignacio R, Kaboord B. 2003. Selective enrichment of membrane proteins by partition phase separation for proteomic studies. J Biomed Biotechnol 2003:249-255.
22. Reczek D, Schwake M, Schroder J, Hughes H, Blanz J, Jin X, Brondyk W, Van Patten S, Edmunds T, Saftig P. 2007. LIMP-2 is a receptor for lysosomal mannose-6-phosphate-independent targeting of beta-glucocerebrosidase. Cell 131:770-783.
23. Santavuori P. 1988. Neuronal ceroid-lipofuscinoses in childhood. Brain Dev 10:80-83.
24. Savukoski M, Klockars T, Holmberg V, Santavuori P, Lander ES, Peltonen L. 1998. CLN5, a novel gene encoding a putative transmembrane protein mutated in Finnish variant late infantile neuronal ceroid lipofuscinosis. Nat Genet 19:286-288.
25. Schmiedt ML, Bessa C, Heine C, Ribeiro MG, Jalanko A, Kyttala A. 2010. The neuronal ceroid lipofuscinosis protein CLN5: new insights into cellular maturation, transport, and consequences of mutations. Hum Mutat 31:356-365.
26. Shih YL, Huang KF, Lai HM, Liao JH, Lee CS, Chang CM, Mak HM, Hsieh CW, Lin CC. 2011. The N-terminal amphipathic helix of the topological specificity factor MinE is associated with shaping membrane curvature. PLoS One 6:e21425.
27. Simmons DL, Botting RM, Hla T. 2004. Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacol Rev 56:387-437.
28. Sleat DE, Wang Y, Sohar I, Lackland H, Li Y, Li H, Zheng H, Lobel P. 2006a. Identification and validation of mannose 6-phosphate glycoproteins in human plasma reveal a wide range of lysosomal and non-lysosomal proteins. Mol Cell Proteomics 5:1942-1956.
29. Sleat DE, Zheng H, Qian M, Lobel P. 2006b. Identification of sites of mannose 6-phosphorylation on lysosomal proteins. Mol Cell Proteomics 5:686-701.
30. Stern O, Hung YF, Valdau O, Yaffe Y, Harris E, Hoffmann S, Willbold D, Sklan EH. 2013. An N-terminal amphipathic helix in dengue virus nonstructural protein 4A mediates oligomerization and is essential for replication. J Virol 87:4080-4085.
31. Vander Heyden AB, Naismith TV, Snapp EL, Hanson PI. 2011. Static retention of the lumenal monotopic membrane protein torsinA in the endoplasmic reticulum. EMBO J 30:3217-3231.
32. Vesa J, Chin MH, Oelgeschlager K, Isosomppi J, DellAngelica EC, Jalanko A, Peltonen L. 2002. Neuronal ceroid lipofuscinoses are connected at molecular level: interaction of CLN5 protein with CLN2 and CLN3. Mol Biol Cell 13:2410-2420.
33. Wimley WC, White SH. 1996. Experimentally determined hydrophobicity scale for proteins at membrane interfaces. Nat Struct Biol 3:842-848.